Skip to main content
. 2020 Mar 25;11:431. doi: 10.3389/fimmu.2020.00431

Figure 4.

Figure 4

Vaccination and protection against challenge with H7N1 influenza. (A) BALB/c mice (n = 10 mice/group) were immunized on days 0 and 28, as indicated by arrows, and sera analyzed for development of IgG responses against recombinant HA from PR8 (H1N1), A/Hong Kong/1/1968 (H3N2), A/Hong Kong/483/97 (H5N1), A/Shanghai/1/2013 (H7N9), and A/Hong Kong/1073/99 (H9N2). Values given are mean ± SEM. *p < 0.05 as compared to NaCl (two-way ANOVA and Bonferroni post-test). (B) At day 49 after vaccination, mice were challenged with 5 × LD50 of influenza A/turkey/Italy/3889/1999 (H7N1) and monitored for weight (B) and survival (C).